Clinical Trial Update: ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study [Phase 2, Phase 3]

View source ↗

Summary

Open-label pilot study of ACTHAR Gel for sarcoidosis-associated calcium dysregulation (hypercalcemia), spanning Phase 2 and Phase 3, with current status listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia
• Sarcoidosis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Albany Medical College | Conditions: Sarcoidosis, Hypercalcemia Due to Sarcoidosis | Phase 2, Phase 3 | Status: UNKNOWN